233 related articles for article (PubMed ID: 15772141)
1. Panresistance in VIM-1-producing Klebsiella pneumoniae.
Miriagou V; Tzelepi E; Daikos GL; Tassios PT; Tzouvelekis LS
J Antimicrob Chemother; 2005 May; 55(5):810-1. PubMed ID: 15772141
[No Abstract] [Full Text] [Related]
2. Comparative in vitro killing of carbapenems and aztreonam against Klebsiella pneumoniae producing VIM-1 metallo-beta-lactamase.
Panagiotakopoulou A; Daikos GL; Miriagou V; Loli A; Tzelepi E; Tzouvelekis LS
Int J Antimicrob Agents; 2007 Mar; 29(3):360-2. PubMed ID: 17223016
[No Abstract] [Full Text] [Related]
3. Ongoing epidemic of blaVIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey.
Psichogiou M; Tassios PT; Avlamis A; Stefanou I; Kosmidis C; Platsouka E; Paniara O; Xanthaki A; Toutouza M; Daikos GL; Tzouvelekis LS
J Antimicrob Chemother; 2008 Jan; 61(1):59-63. PubMed ID: 17999975
[TBL] [Abstract][Full Text] [Related]
4. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium.
Bogaerts P; Montesinos I; Rodriguez-Villalobos H; Blairon L; Deplano A; Glupczynski Y
J Antimicrob Chemother; 2010 Feb; 65(2):361-2. PubMed ID: 20008447
[No Abstract] [Full Text] [Related]
5. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.
Meletis G; Tzampaz E; Sianou E; Tzavaras I; Sofianou D
J Antimicrob Chemother; 2011 Apr; 66(4):946-7. PubMed ID: 21393203
[No Abstract] [Full Text] [Related]
6. Resistance status and evolution trends of Klebsiella pneumoniae isolates in a university hospital in Greece: ineffectiveness of carbapenems and increasing resistance to colistin.
Neonakis IK; Samonis G; Messaritakis H; Baritaki S; Georgiladakis A; Maraki S; Spandidos DA
Chemotherapy; 2010; 56(6):448-52. PubMed ID: 21088396
[TBL] [Abstract][Full Text] [Related]
7. Emergence of Klebsiella pneumoniae of a novel sequence type (ST383) producing VIM-4, KPC-2 and CMY-4 β-lactamases.
Papagiannitsis CC; Giakkoupi P; Vatopoulos AC; Tryfinopoulou K; Miriagou V; Tzouvelekis LS
Int J Antimicrob Agents; 2010 Dec; 36(6):573-4. PubMed ID: 20863669
[No Abstract] [Full Text] [Related]
8. Outbreak caused by a multidrug-resistant Klebsiella pneumoniae clone carrying blaVIM-12 in a university hospital.
Tokatlidou D; Tsivitanidou M; Pournaras S; Ikonomidis A; Tsakris A; Sofianou D
J Clin Microbiol; 2008 Mar; 46(3):1005-8. PubMed ID: 18199780
[TBL] [Abstract][Full Text] [Related]
9. Re: A VIM-1-metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Shah PM
Int J Antimicrob Agents; 2009 Oct; 34(4):381. PubMed ID: 19502012
[No Abstract] [Full Text] [Related]
10. Detection of GES-5-producing Klebsiella pneumoniae in Brazil.
Picão RC; Santos AF; Nicoletti AG; Furtado GH; Gales AC
J Antimicrob Chemother; 2010 Apr; 65(4):796-7. PubMed ID: 20139141
[No Abstract] [Full Text] [Related]
11. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece.
Pournaras S; Protonotariou E; Voulgari E; Kristo I; Dimitroulia E; Vitti D; Tsalidou M; Maniatis AN; Tsakris A; Sofianou D
J Antimicrob Chemother; 2009 Aug; 64(2):348-52. PubMed ID: 19525514
[TBL] [Abstract][Full Text] [Related]
12. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark.
Hammerum AM; Hansen F; Lester CH; Jensen KT; Hansen DS; Dessau RB
Int J Antimicrob Agents; 2010 Jun; 35(6):610-2. PubMed ID: 20206479
[No Abstract] [Full Text] [Related]
13. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Pai H; Seo MR; Choi TY
Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
[TBL] [Abstract][Full Text] [Related]
14. A VIM-1 metallo-beta-lactamase-producing Klebsiella pneumoniae clinical isolate in an acute hospital in Germany.
Weile J; Ohler S; Schönthal S; Knabbe C
Int J Antimicrob Agents; 2009 Apr; 33(4):389-91. PubMed ID: 19108993
[No Abstract] [Full Text] [Related]
15. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
Conejo MC; Hernández JR; Pascual A
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
[TBL] [Abstract][Full Text] [Related]
16. Occurrence of KPC-2-producing Klebsiella pneumoniae strains in hospital wastewater.
Chagas TP; Seki LM; da Silva DM; Asensi MD
J Hosp Infect; 2011 Mar; 77(3):281. PubMed ID: 21216031
[No Abstract] [Full Text] [Related]
17. Klebsiellapneumoniae isolates possessing KPC beta-lactamase in Israel, Puerto Rico, Colombia and Greece.
Hawser SP; Bouchillon SK; Hoban DJ; Hackel M; Johnson JL; Badal RE
Int J Antimicrob Agents; 2009 Oct; 34(4):384-5. PubMed ID: 19560904
[No Abstract] [Full Text] [Related]
18. Emergence of NDM-producing Klebsiella pneumoniae in Greece.
Giakkoupi P; Tryfinopoulou K; Kontopidou F; Tsonou P; Golegou T; Souki H; Tzouvelekis L; Miriagou V; Vatopoulos A
Diagn Microbiol Infect Dis; 2013 Dec; 77(4):382-4. PubMed ID: 24135413
[No Abstract] [Full Text] [Related]
19. Emergence of an extensively drug-resistant ArmA- and KPC-2-producing ST101 Klebsiella pneumoniae clone in Italy.
Mezzatesta ML; Gona F; Caio C; Adembri C; Dell'utri P; Santagati M; Stefani S
J Antimicrob Chemother; 2013 Aug; 68(8):1932-4. PubMed ID: 23667172
[No Abstract] [Full Text] [Related]
20. Multiclonal emergence of carbapenem-resistant Klebsiella pneumoniae in Tuscany, Italy.
Mammina C; Aleo A; Bonura C; Calà C; Degl'Innocenti R; Conti A; Pecile P; Pesavento G; Nastasi A
Int J Antimicrob Agents; 2010 Dec; 36(6):576-8. PubMed ID: 20869854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
